Maven Securities’s Biohaven BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-225,000
Closed -$5.85M 937
2023
Q3
$5.85M Buy
225,000
+25,000
+13% +$520K 0.07% 167
2023
Q2
$4.78M Sell
200,000
-50,000
-20% -$861K 0.07% 138
2023
Q1
$3.42M Sell
250,000
-294,050
-54% -$4.68M 0.07% 187
2022
Q4
$7.55M Buy
+544,050
New +$7.68M 0.17% 69

Other funds holding BHVN

Maven Securities's BHVN Position: Q4 2023 in Review

Maven Securities sold out of Biohaven (BHVN) in Q4 2023, closing a stake of 225,000 shares — an estimated $5.85M sold.

Maven Securities first reported a position in BHVN in Q4 2022 and held it in 4 quarters. The position peaked at $7.55M in Q4 2022. 218 funds tracked by Wall St. Rank hold BHVN as of Q4 2023.

  • Maven Securities reported no remaining Biohaven position as of Q4 2023 after selling out during the quarter.
  • Maven Securities sold 225,000 Biohaven shares in Q4 2023, an estimated $5.85M.
  • Maven Securities first reported a position in Biohaven in Q4 2022 and held it in 4 quarters.
  • Maven Securities's Biohaven position peaked at $7.55M in Q4 2022.
  • 218 funds tracked by Wall St. Rank held Biohaven as of Q4 2023.

Based on Maven Securities's 13F filing for Q4 2023, filed 12 Feb 2024.